Enhanced external counterpulsation (EECP) decreases advanced glycation end products and proinflammatory cytokines in patients with non-insulin-dependent type II diabetes mellitus for up to 6 months following treatment

2016 ◽  
Vol 53 (5) ◽  
pp. 753-760 ◽  
Author(s):  
Paloma D. Sardina ◽  
Jeffrey S. Martin ◽  
Wojciech K. Dzieza ◽  
Randy W. Braith
1996 ◽  
Vol 47 (1) ◽  
pp. 509-531 ◽  
Author(s):  
C. Ronald Kahn, M.D ◽  
David Vicent, M.D ◽  
Alessandro Doria, M.D., Ph.D

Sign in / Sign up

Export Citation Format

Share Document